vendredi 6 novembre 2015

Onco Actu du 6 novembre 2015

2.11 Etiologie - Alimentation

Red meat makes a good, scary cancer story....but is it? [The Mermaid's Tale]

Know your risks, but meat still isn’t the enemy [The Incidental Economist]

3.3 Prévention - Vaccins

HPV vaccine doesn't cause chronic pain, review finds [STAT]

Review concludes evidence does not support that HPV vaccines cause CRPS or POTS [EMA]

3.4 Chimioprévention

First precision medicine trial in cancer prevention identifies molecular-based chemoprevention strategy [MD Anderson Cancer Center]

4.12 Biopsies liquides

Blood test could help improve prostate cancer outcomes [NHS Choices]

5. Traitements

Patient-Derived Tumour Xenograft Models Encyclopedia [ESMO]

Gut microbes give anticancer treatments a boost [Science]

Vitamin C kills tumor cells with hard-to-treat mutation [Science]

5.2 Pharma

Global Analysis Of Metastatic Breast Cancer Landscape Reveals Gaps In Patient Care And Support [Pfizer]

5.2.3 Pharma - économie

GSK, Gates Foundation help immuno-oncology player to $56M Series A round [FierceBiotech]

5.3 Traitements - FDA, EMA,...

European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) in Previously Treated Advanced Renal Cell Carcinoma [BMS]

5.4 Traitements - Economie

Medicines for breast cancer: the affordability controversy [Institute of Cancer Policy]

5.8.1 ASH - Communiqués

ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting [ARIAD Pharmaceuticals]

Seattle Genetics Announces More Than 20 Presentations at ASH 2015 Highlighting Progress with Broad ADCETRIS® (Brentuximab Vedotin) Development Plan and Multiple Antibody-Drug Conjugate (ADC) Pipeline Programs [Seattle Genetics]

Roche to present new clinical data across a variety of blood diseases at American Society of Hematology 2015 Annual Meeting [Roche]

Takeda to Present Data from Ixazomib's Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting [Takeda]

Janssen to Showcase Growing Portfolio with More Than 40 Data Presentations at the 2015 American Society of Hematology (ASH) Annual Meeting [Johnson & Johnson]

AbbVie's Commitment to Oncology Demonstrated at the 57th American Society of Hematology Annual Meeting with 61 Abstracts Evaluating Medicines in Several Blood Cancers [AbbVie]

5.8.4 ASH - CAR T

Juno, Kite, Novartis Yelp 'Oh Merde!' at Collects Off-the-Shelf CAR-T Data [TheStreet]

Gene Editing Credited With Eliminating an Infant's Aggressive Cancer in London [Wall Street Journal]

Leukaemia success heralds wave of gene-editing therapies [Nature News & Comment]

Gene editing tool used to treat girl's cancer in medical first [STAT]

UCART19: First in Man Proof of Concept to be Presented at 2015 ASH Annual Meeting [Cellectis]

A Cell Therapy Untested in Humans Saves a Baby With Cancer [NY Times]

Baby girl is first in the world to be treated with 'designer immune cells' [The Guardian]

New kind of "designer" immune cells clear baby's leukaemia [Reuters]

Parents who refused to let baby die of leukaemia change medical history [The Telegraph]

6. Lutte contre les cancers

NCRI cancer conference day 4: the cost of cancer care and the immune system (again) [Cancer Research UK]

6.5 Médecines alternatives

Well: Living With Cancer: The Lure of Alternative Remedies [NY Times]

6.7 DMP, Big Data & applis

Conquer Cancer Foundation of ASCO Receives Additional $1 Million Donation from Susan G. Komen® for Development of CancerLinQ™ [ASCO]

6.8 Communication

Advantage Humans: New Campaign Changes the Conversation [ACS]